Stock Earnings in Review: Pfizer Inc. (NYSE:PFE)

Shares of Pfizer Inc. (NYSE:PFE) jumped 1.34% to reach at $31.73 during previous trading session. The company has experienced volume of 37,422,335 shares while on average the company has a capacity of trading 28.35M share.

Pfizer Inc. (NYSE:PFE) Pfizer Inc. (PFE) on January 31, 2017 reported financial results for fourth-quarter and full-year 2016.

Pfizer manages its commercial operations through two distinct businesses: Pfizer Innovative Health (IH) (formerly the Innovative Products business) and Pfizer Essential Health (EH) (formerly the Established Products business).

On September 3, 2015, Pfizer acquired Hospira, Inc. (Hospira). Consequently, financial results for the year ended December 31, 2016 reflect legacy Hospira global operations for the entire period while financial results for the year ended December 31, 2015 reflect only four months of legacy Hospira U.S. operations and three months of legacy Hospira international operations. Financial results for fourth-quarter 2016 and fourth-quarter 2015 include legacy Hospira global operations for both periods.

On June 24, 2016, Pfizer acquired Anacor Pharmaceuticals, Inc. (Anacor). Therefore, financial results for fourth-quarter and full-year 2016 reflect three months and approximately six months of legacy Anacor operations, respectively, which were immaterial.

On September 28, 2016, Pfizer acquired Medivation, Inc. (Medivation). Therefore, financial results for fourth-quarter and full-year 2016 reflect three months of legacy Medivation operations.

Pfizer Inc. (NYSE:PFE) holds the market capitalization of $195.13B along with 6.07B outstanding shares. During the last trade, stock’s minimum price has been reached out at $30.93 while the maximum trading price moved at $31.93. Currently the stock price is moving -13.58% off from the highest level of twelve months and +15.41% above from twelve months low. Pfizer Inc. (NYSE:PFE) marked 52-week highest price level of $36.72 on 08/01/16 and 52-week lowest price level of $27.49 on 02/08/16. For the stock, price target value has been calculated at $37.48 based on calls of 21 experts. Stock’s minimum price target estimates has been figured out at $30.00 while the maximum price target forecast is established at $52.00.

As of current trade, Pfizer Inc. (NYSE:PFE) has shown weekly upbeat performance of 1.86%. Its six months performance indicated a bearish movement while its yearly performance reflected a positive trend of 9.15%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -2.31%. Shares of Pfizer Inc. (NYSE:PFE) currently have an ABR of 2.06, derived from a total of 17 opinions. The company’s price sits -1.27% below from its 50-day moving average of $32.41 and -4.64% below from the stock’s 200-day moving average of $33.33. The company has Relative Strength Index (RSI 14) of 44.51 along with Average True Range (ATR 14) of 0.47. Its weekly and monthly volatility is 1.55%, 1.46% respectively. The company’s beta value is at 0.92.

Pfizer Inc. (NYSE:PFE) currently has a PEG ratio of 4.48 where as its P/E ratio is 31.67. The company’s price to sales ratio for trailing twelve months is 3.62 and price to book ratio for most recent quarter is 3.04, whereas price to cash per share for the most recent quarter is 13.40. Pfizer Inc. (NYSE:PFE)’s price to free cash flow for trailing twelve months is 108.11. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48. Pfizer Inc. (NYSE:PFE) has a Return on Assets of 3.60%. The company currently has a Return on Equity of 9.70% and Return on Investment of 7.30%.

Pfizer Inc. (NYSE:PFE): Can the Stock Surprise in Next Earnings?

Pfizer Inc. (NYSE:PFE) plunged -0.38% or -0.12 points during previous trade after opening at the price of $31.47, a total of 27,424,200 shares exchanged hands compared with its average trading volume of 28.33M shares. The stock has a market capitalization of $190.85B and it has 6.07B outstanding shares.

According to consensus agreement of 18 analysts Pfizer Inc. (NYSE:PFE) will report earnings per share of $0.5 in their quarterly report and it is expected to announce the company’s results on 1/31/17 Before Market Open. The stock added almost 0.1% in price since last earning report, when its share price was $31.40. For the current quarter the company has highest EPS estimates of $0.54 and low forecast is $0.47. However a year ago for the same quarter the company has reported $0.53 earnings per share.

Earnings reaction history indicates that share price went down 15 times out of last 28 quarters. In Pfizer Inc. (NYSE:PFE)’s last 12 earnings reports, it has beaten EPS estimates 91% of the time. However it has meet the estimates 0 time and missed 1 time.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 9/2016, the consensus mean EPS was $0.62 while Pfizer Inc. (NYSE:PFE) reported $0.61 EPS on 11/1/2016 Before Market Open with a difference of -0.01 marking a surprise factor of -1.61%. The stock’s next day closing price was $30.76 with the loss of -2.04% in its share price. On seventh day of the earnings report price change of the stock was -4.20%.

Previously for the quarter ended on 6/2016, Pfizer Inc. (NYSE:PFE)’s expected mean EPS was $0.62, the company reported its quarterly earnings per share of $0.64 on 8/2/2016 Before Market Open, beating the analysts’ consensus estimate by 0.02 with surprise factor of 3.23%. The stock’s closing price was $35.73 with the loss of -2.46% in its share price on the day following the earning announcement. However price change of the stock was -5.60% on seventh day of the earnings report.

Pfizer Inc. (NYSE:PFE)’s mean EPS estimate was $0.55 for the quarter ended on 3/2016, while it reported EPS of $0.67 on 5/3/2016 Before Market Open, beating the analysts’ consensus estimate by 0.12 with surprise factor of 21.82%. On next day when data was publically announced, the stock’s closing price was $32.79 with 2.76% gain in its share price. On seventh day of the earnings report price change of the stock was up 3.13%.

Back on 2/2/2016 the company’s estimated EPS value was $0.52 and it reported $0.53 earnings per share (EPS) for the quarter ended on 12/2015. The company posted a positive surprise factor of 1.92% by 0.01.

Average EPS forecast for the current year is $2.41 according to 20 analysts making projections for Pfizer Inc. (NYSE:PFE). The most expectant earnings per share estimate of the stock is set at $2.45 while the conservative estimates kept at $2.38 over the current year. Having a look at the historical EPS report, the company attained $2.2 EPS for the previous year. While revenue estimates for the current year is $52.86B, Pfizer Inc. (NYSE:PFE) setting the highest revenues estimates of $53.57B and indicating lowest revenues at $52.11B according to agreement of 17 number of analysts. Current quarter revenue movements show that, the company has set average revenue estimates of $13.63B covering forecast of 16 analysts. The company indicates a peak revenue level of $14.37B and $12.91B at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of -5.70% whereas for next quarter it has -1.50% estimations over growth. Its forecasts over growth are 9.50% during current year while analysts’ growth estimation for the next year is 6.60%. Past 5 years growth of Pfizer Inc. (NYSE:PFE) observed at 1.78%, and for the next five years the analysts that follow this company are expecting its growth at 7.12%.

Pfizer Inc. (NYSE:PFE) reached at $31.31 price level during last trade its distance from 20 days simple moving average is -3.27%, and its distance from 50 days simple moving average is -2.64% while it has a distance of -5.91% from the 200 days simple moving average. One year trading price range hit the peak level of $36.72 and touched the lowest level of $27.49. The company’s distance from 52-week high price is -14.72% and current price is above +13.88% from 52-week low price.

Trader’s Buzzer: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.25% or -0.08 points to reach at $32.52 during previous trading session. The stock’s price fluctuated within the range of $32.33 – $32.78 during previous trading session. A total of 20,274,122 shares exchanged hands, whereas the company’s average trading volume stands at 26.85M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $196.86B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 46.17.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 14 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -0.99% whereas its distance from 50 day simple moving average is 1.48% along with -2.14% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.43% below from the 52-week high mark of $36.72 and +18.28% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -2.87% in the past one week and plunged -0.94% during previous one month drive, the stock went up 0.26% during past quarter. In the last six months the stock’s performance fell -9.93% while yearly performance of the company advanced 8.49%. The company’s year to date (YTD) performance is at 0.12%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.49, along with its weekly and monthly volatility of 1.56%, 1.24% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 111.08. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Investor’s Alert: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.09% or -0.03 points to reach at $33.44 during previous trading session. The stock’s price fluctuated within the range of $33.32 – $33.66 during previous trading session. A total of 19,368,800 shares exchanged hands, whereas the company’s average trading volume stands at 6.07B shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $202.87B and most recently 26.22M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 63.69.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 14 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 2.12% whereas its distance from 50 day simple moving average is 4.60% along with 0.80% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -8.92% below from the 52-week high mark of $36.72 and +21.63% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 1.33% in the past one week and soared 8.08% during previous one month drive, the stock went up 0.49% during past quarter. In the last six months the stock’s performance fell -6.03% while yearly performance of the company advanced 11.70%. The company’s year to date (YTD) performance is at 2.96%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.44, along with its weekly and monthly volatility of 1.13%, 1.28% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 114.38. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock in Limelight: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.03% or -0.01 points to reach at $32.48 during previous trading session. The stock’s price fluctuated within the range of $32.31 – $32.60 during previous trading session. A total of 18.87M shares exchanged hands, whereas the company’s average trading volume stands at 23.86M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $197.04B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 56.31.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.87% whereas its distance from 50 day simple moving average is 2.05% along with -1.73% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.54% below from the 52-week high mark of $36.72 and +18.13% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.43% in the past one week and soared 1.06% during previous one month drive, the stock went down -3.15% during past quarter. In the last six months the stock’s performance fell -7.01% while yearly performance of the company advanced 4.42%. The company’s year to date (YTD) performance is at 4.42%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.45, along with its weekly and monthly volatility of 0.82%, 1.44% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.63. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock on Trader’s Radar: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.19% or -0.06 points to reach at $32.34 during previous trading session. The stock’s price fluctuated within the range of $32.05 – $32.43 during previous trading session. A total of 18,582,400 shares exchanged hands, whereas the company’s average trading volume stands at 26.40M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $193.56B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 52.60.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.65. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $30.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.98% whereas its distance from 50 day simple moving average is 1.62% along with -1.89% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -11.92% below from the 52-week high mark of $36.72 and +17.62% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -1.25% in the past one week and soared 3.22% during previous one month drive, the stock went down -4.66% during past quarter. In the last six months the stock’s performance fell -3.05% while yearly performance of the company advanced 3.08%. The company’s year to date (YTD) performance is at 3.97%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.54, along with its weekly and monthly volatility of 1.21%, 1.60% respectively. Beta value of the stock stands at 0.90.

The company’s price to free cash flow for trailing twelve months is 110.15. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock to Keep Your Eyes on: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price soared 0.27% or +0.09 points to reach at $32.84 during previous trading session. The stock’s price fluctuated within the range of $32.52 – $32.94 during previous trading session. A total of 36,843,862 shares exchanged hands, whereas the company’s average trading volume stands at 25.93M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $198.86B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 59.87.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.85. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 3.32% whereas its distance from 50 day simple moving average is 3.08% along with -0.14% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -10.56% below from the 52-week high mark of $36.72 and +19.44% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 3.60% in the past one week and soared 2.75% during previous one month drive, the stock went down -1.43% during past quarter. In the last six months the stock’s performance fell -3.06% while yearly performance of the company advanced 5.42%. The company’s year to date (YTD) performance is at 5.58%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.70, along with its weekly and monthly volatility of 1.71%, 1.69% respectively. Beta value of the stock stands at 0.89.

The company’s price to free cash flow for trailing twelve months is 111.85. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Notable Mover: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price soared 2.46% or +0.76 points to reach at $31.70 during previous trading session. The stock’s price fluctuated within the range of $31.09 – $31.92 during previous trading session. A total of 29.35M shares exchanged hands, whereas the company’s average trading volume stands at 32.99M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $195.51B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 50.25.

According to sentiments of 20 analysts the mean estimates of short term price target for the company’s stock is marked at $37.85. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 4 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.67B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.53B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -0.29% whereas its distance from 50 day simple moving average is -0.77% along with -3.36% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -13.66% below from the 52-week high mark of $36.72 and +15.30% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.22% in the past one week and plunged -1.31% during previous one month drive, the stock went down -7.60% during past quarter. In the last six months the stock’s performance fell -7.07% while yearly performance of the company advanced 1.67%. The company’s year to date (YTD) performance is at 1.92%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.73, along with its weekly and monthly volatility of 1.81%, 1.90% respectively. Beta value of the stock stands at 0.91.

The company’s price to free cash flow for trailing twelve months is 107.97. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock to Watch: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged 0.54% or +0.17 points to reach at $31.63 during previous trading session. The stock’s price fluctuated within the range of $31.36– $31.73 during previous trading session. A total of 19.01M shares exchanged hands, whereas the company’s average trading volume stands at 31.61M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $187.88B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 47.43.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.76. The most optimistic analyst sees the stock reaching $53.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 15 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 3 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.61B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.37B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.27 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 5 have given the stock a Buy while 6 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is 0.34% whereas its distance from 50 day simple moving average is -1.69% along with -3.42% distance from 200 day simple moving average.

Important factors to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -13.85% below from the 52-week high mark of $36.72 and +15.04% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -0.19% in the past one week and soared 4.29% during previous one month drive, the stock went down -8.12% during past quarter. In the last six months the stock’s performance fell -7.78% while yearly performance of the company advanced 1.35%. The company’s year to date (YTD) performance is at 1.69%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.68, along with its weekly and monthly volatility of 1.61%, 2.11% respectively. Beta value of the stock stands at 0.89.

The company’s price to free cash flow for trailing twelve months is 107.77. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Trader’s Buzzer: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.27% or -0.08 points to reach at $30 during previous trading session. The stock’s price fluctuated within the range of $29.96 – $30.45 during previous trading session. A total of 35.45M shares exchanged hands, whereas the company’s average trading volume stands at 22.44M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $ 184.27B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 23.72.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.86. The most optimistic analyst sees the stock reaching $53 while the most conventional predicts the target price at $33.

The consensus mean EPS for the current quarter is at $0.51 derived from a total of 16 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.6. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.64 per share according to consensus of 3 analysts.

According to sentiments of 13 analysts the company is expected to report revenues of $13.66B for the current quarter. Bearish revenue estimates established at $12.95B while the bullish revenue forecast has been figured out at $14.37B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.27 on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 5 have given the stock a Buy while 6 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc. (NYSE:PFE)’s distance from 20 day simple moving average is -6.11% whereas its distance from 50 day simple moving average is -9.82% along with -8.58% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading -19.10% below from the 52-week high mark of $37.08 and +8.04% above from the 52-week bottom of $27.77. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 02/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -3.44% in the past one week and plunged -10.74% during previous one month drive, the stock went down -14.60% during past quarter. In the last six months the stock’s performance fell -8.78% while yearly performance of the company fell -8.39%. The company’s year to date (YTD) performance is at -4.50%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.50, along with its weekly and monthly volatility of 1.91%, 1.43% respectively. Beta value of the stock stands at 0.90.